These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9635830)

  • 41. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between smoking and p53 mutation in lung cancer: a meta-analysis.
    Liu X; Lin XJ; Wang CP; Yan KK; Zhao LY; An WX; Liu XD
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):18-24. PubMed ID: 24126199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
    Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
    Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The TP53 gene, tobacco exposure, and lung cancer.
    Toyooka S; Tsuda T; Gazdar AF
    Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the origin of p53 G:C --> T:A transversions in lung cancers.
    Rodin SN; Rodin AS
    Mutat Res; 2002 Oct; 508(1-2):1-19. PubMed ID: 12379456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.
    Guinee DG; Travis WD; Trivers GE; De Benedetti VM; Cawley H; Welsh JA; Bennett WP; Jett J; Colby TV; Tazelaar H
    Carcinogenesis; 1995 May; 16(5):993-1002. PubMed ID: 7767998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus.
    Marchetti A; Pellegrini S; Sozzi G; Bertacca G; Gaeta P; Buttitta F; Carnicelli V; Griseri P; Chella A; Angeletti CA; Pierotti M; Bevilacqua G
    Br J Cancer; 1998 Jul; 78(1):73-8. PubMed ID: 9662254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.
    Medina PP; Ahrendt SA; Pollan M; Fernandez P; Sidransky D; Sanchez-Cespedes M
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):699-704. PubMed ID: 12917199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung tumours from non-smoking subjects: A p53-related genetic instability in a subset of cases.
    Pellegrini S; Bertacca G; Buttitta F; Bevilacqua G; Marchetti A
    Int J Mol Med; 1999 Oct; 4(4):419-24. PubMed ID: 10493985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
    Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
    J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong.
    Takagi Y; Koo LC; Osada H; Ueda R; Kyaw K; Ma CC; Suyama M; Saji S; Takahashi T; Tominaga S
    Cancer Res; 1995 Nov; 55(22):5354-7. PubMed ID: 7585600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
    Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
    J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
    J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.
    Gao W; Mady HH; Melhem MF; Keohavong P
    Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.